Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase

James E Dunford, Aaron A Kwaasi, Michael J Rogers, Bobby L Barnett, Frank H Ebetino, R Graham G Russell, Udo Oppermann, Kathryn L Kavanagh

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

The nitrogen-containing bisphosphonates (N-BPs) are the main drugs currently used to treat diseases characterized by excessive bone resorption. The major molecular target of N-BPs is farnesylpyrophosphate synthase. N-BPs inhibit the enzyme by a mechanism that involves time dependent isomerization of the enzyme. We investigated features of N-BPs that confer maximal slow and tight-binding by quantifying the initial and final K(i)s and calculating the isomerization constant K(isom) for many N-BPs. Disruption of the phosphonate-carbon-phosphonate backbone resulted in loss of potency and reduced K(isom). The lack of a hydroxyl group on the geminal carbon also reduced K(isom). The position of the nitrogen in the side chain was crucial to both K(i) and K(isom). A correlation of K(isom) and also final K(i) with previously published in vivo potency reveals that the isomerization constant ( R = -0.77, p <0.0001) and the final inhibition of FPPS by N-BPs ( R = 0.74, p <0.0001) are closely linked to antiresorptive efficacy.
Original languageEnglish
Pages (from-to)2187-2195
Number of pages9
JournalJournal of Medicinal Chemistry
Volume51
Issue number7
Early online date8 Mar 2008
DOIs
Publication statusPublished - Jul 2008

Fingerprint

Diphosphonates
Structure-Activity Relationship
Nitrogen
Organophosphonates
Carbon
Enzymes
Bone Resorption
Hydroxyl Radical
farnesyl pyrophosphate
Pharmaceutical Preparations

Keywords

  • Binding Sites
  • Diphosphonates
  • Enzyme Inhibitors
  • Geranyltranstransferase
  • Humans
  • Models, Molecular
  • Molecular Structure
  • Nitrogen
  • Stereoisomerism
  • Structure-Activity Relationship
  • Time Factors

Cite this

Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues : time-dependent inhibition of human farnesyl pyrophosphate synthase. / Dunford, James E; Kwaasi, Aaron A; Rogers, Michael J; Barnett, Bobby L; Ebetino, Frank H; Russell, R Graham G; Oppermann, Udo; Kavanagh, Kathryn L.

In: Journal of Medicinal Chemistry, Vol. 51, No. 7, 07.2008, p. 2187-2195.

Research output: Contribution to journalArticle

Dunford, James E ; Kwaasi, Aaron A ; Rogers, Michael J ; Barnett, Bobby L ; Ebetino, Frank H ; Russell, R Graham G ; Oppermann, Udo ; Kavanagh, Kathryn L. / Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues : time-dependent inhibition of human farnesyl pyrophosphate synthase. In: Journal of Medicinal Chemistry. 2008 ; Vol. 51, No. 7. pp. 2187-2195.
@article{943bc64d1e7e4e9687bb5ba41426dd4d,
title = "Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase",
abstract = "The nitrogen-containing bisphosphonates (N-BPs) are the main drugs currently used to treat diseases characterized by excessive bone resorption. The major molecular target of N-BPs is farnesylpyrophosphate synthase. N-BPs inhibit the enzyme by a mechanism that involves time dependent isomerization of the enzyme. We investigated features of N-BPs that confer maximal slow and tight-binding by quantifying the initial and final K(i)s and calculating the isomerization constant K(isom) for many N-BPs. Disruption of the phosphonate-carbon-phosphonate backbone resulted in loss of potency and reduced K(isom). The lack of a hydroxyl group on the geminal carbon also reduced K(isom). The position of the nitrogen in the side chain was crucial to both K(i) and K(isom). A correlation of K(isom) and also final K(i) with previously published in vivo potency reveals that the isomerization constant ( R = -0.77, p <0.0001) and the final inhibition of FPPS by N-BPs ( R = 0.74, p <0.0001) are closely linked to antiresorptive efficacy.",
keywords = "Binding Sites, Diphosphonates, Enzyme Inhibitors, Geranyltranstransferase, Humans, Models, Molecular, Molecular Structure, Nitrogen, Stereoisomerism, Structure-Activity Relationship, Time Factors",
author = "Dunford, {James E} and Kwaasi, {Aaron A} and Rogers, {Michael J} and Barnett, {Bobby L} and Ebetino, {Frank H} and Russell, {R Graham G} and Udo Oppermann and Kavanagh, {Kathryn L}",
year = "2008",
month = "7",
doi = "10.1021/jm7015733",
language = "English",
volume = "51",
pages = "2187--2195",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "AMER CHEMICAL SOC",
number = "7",

}

TY - JOUR

T1 - Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues

T2 - time-dependent inhibition of human farnesyl pyrophosphate synthase

AU - Dunford, James E

AU - Kwaasi, Aaron A

AU - Rogers, Michael J

AU - Barnett, Bobby L

AU - Ebetino, Frank H

AU - Russell, R Graham G

AU - Oppermann, Udo

AU - Kavanagh, Kathryn L

PY - 2008/7

Y1 - 2008/7

N2 - The nitrogen-containing bisphosphonates (N-BPs) are the main drugs currently used to treat diseases characterized by excessive bone resorption. The major molecular target of N-BPs is farnesylpyrophosphate synthase. N-BPs inhibit the enzyme by a mechanism that involves time dependent isomerization of the enzyme. We investigated features of N-BPs that confer maximal slow and tight-binding by quantifying the initial and final K(i)s and calculating the isomerization constant K(isom) for many N-BPs. Disruption of the phosphonate-carbon-phosphonate backbone resulted in loss of potency and reduced K(isom). The lack of a hydroxyl group on the geminal carbon also reduced K(isom). The position of the nitrogen in the side chain was crucial to both K(i) and K(isom). A correlation of K(isom) and also final K(i) with previously published in vivo potency reveals that the isomerization constant ( R = -0.77, p <0.0001) and the final inhibition of FPPS by N-BPs ( R = 0.74, p <0.0001) are closely linked to antiresorptive efficacy.

AB - The nitrogen-containing bisphosphonates (N-BPs) are the main drugs currently used to treat diseases characterized by excessive bone resorption. The major molecular target of N-BPs is farnesylpyrophosphate synthase. N-BPs inhibit the enzyme by a mechanism that involves time dependent isomerization of the enzyme. We investigated features of N-BPs that confer maximal slow and tight-binding by quantifying the initial and final K(i)s and calculating the isomerization constant K(isom) for many N-BPs. Disruption of the phosphonate-carbon-phosphonate backbone resulted in loss of potency and reduced K(isom). The lack of a hydroxyl group on the geminal carbon also reduced K(isom). The position of the nitrogen in the side chain was crucial to both K(i) and K(isom). A correlation of K(isom) and also final K(i) with previously published in vivo potency reveals that the isomerization constant ( R = -0.77, p <0.0001) and the final inhibition of FPPS by N-BPs ( R = 0.74, p <0.0001) are closely linked to antiresorptive efficacy.

KW - Binding Sites

KW - Diphosphonates

KW - Enzyme Inhibitors

KW - Geranyltranstransferase

KW - Humans

KW - Models, Molecular

KW - Molecular Structure

KW - Nitrogen

KW - Stereoisomerism

KW - Structure-Activity Relationship

KW - Time Factors

U2 - 10.1021/jm7015733

DO - 10.1021/jm7015733

M3 - Article

C2 - 18327899

VL - 51

SP - 2187

EP - 2195

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 7

ER -